Alexandre V. Ivachtchenko

AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial

Andrey A. Ivashchenko, Kirill Dmitriev, Natalia Vostokova et al. · Clinical Infectious Diseases · 2020 · 267 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Synthesis and Structure–Activity Relationship (SAR) of (5,7-Disubstituted 3-phenylsulfonyl-pyrazolo[1,5-<i>a</i>]pyrimidin-2-yl)-methylamines as Potent Serotonin 5-HT₆Receptor (5-HT₆R) Antagonists

Alexandre V. Ivachtchenko, Elena S. Golovina, Volodymyr Kysil et al. · Journal of Medicinal Chemistry · 2011 · 106 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Synthesis and Structure−Activity Relationship of 4-Substituted 2-(2-Acetyloxyethyl)-8-(morpholine- 4-sulfonyl)pyrrolo[3,4-<i>c</i>]quinoline- 1,3-diones as Potent Caspase-3 Inhibitors

Yulia A. Kuzovkova, Volodymyr Kysil, Sergey E. Tkachenko et al. · Journal of Medicinal Chemistry · 2005 · 84 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Synthesis and antimicrobial activity of 5-hydroxymethyl- 8-methyl-2-(N-arylimino)-pyrano[2,3-c]pyridine-3-(N-aryl)-carboxamides

Irina Ο. Zhuravel, Sergiy М. Kovalenko, Alexandre V. Ivachtchenko et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 79 citations

Medicine, Medicinal Chemistry, Microbiology +9

Complexity-Enhancing Acid-Promoted Rearrangement of Tricyclic Products of Tandem Ugi 4CC/Intramolecular Diels−Alder Reaction

Alexei Ilyin, Volodymyr Kysil, Mikhail Krasavin et al. · The Journal of Organic Chemistry · 2006 · 72 citations

Natural Sciences, Chemistry, Medicinal Chemistry +10